Jorge E. Cortes, Andreas Hochhaus, Naoto Takahashi, Ghayas C. Issa, Felice Bombaci, Jianxiang Wang, Dong-Wook Kim, Dennis Dong Hwan Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Ihno Kim, Gabriel Etienne, Kamel Malek, Tracey McCulloch, Justin Theodore Wahlstrom, Lillian Yau, Timothy P. Hughes, Richard Larson. "ASC4FIRST wk 144 analysis: Efficacy and safety and tolerability with asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS TKIs) in newly diagnosed (ND) chronic myeloid leukemia in chronic phase (CML-CP).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.6583